AbbVie, Merck & Co., Inc., PepsiCo, Exxon Mobil, and Ford Motor are the five Dividend stocks to watch today, according to MarketBeat's stock screener tool. Dividend stocks are shares of companies that distribute a portion of their earnings to shareholders on a regular basis, usually quarterly. These dividends provide investors with an income stream in addition to any capital gains from share-price appreciation. Companies that pay dividends are often well established and generate steady cash flow. These companies had the highest dollar trading volume of any Dividend stocks within the last several days.
AbbVie (ABBV)
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers.
ABBV stock traded down $4.90 during midday trading on Friday, reaching $181.89. The stock had a trading volume of 29,262,557 shares, compared to its average volume of 6,249,513. The stock has a market cap of $321.29 billion, a PE ratio of 77.40, a P/E/G ratio of 1.21 and a beta of 0.50. The company has a debt-to-equity ratio of 44.14, a quick ratio of 0.64 and a current ratio of 0.76. The firm has a fifty day simple moving average of $186.21 and a two-hundred day simple moving average of $188.01. AbbVie has a 52-week low of $163.52 and a 52-week high of $218.66.
Read Our Latest Research Report on ABBV
Merck & Co., Inc. (MRK)
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products.
MRK stock traded up $0.10 during midday trading on Friday, reaching $78.93. The stock had a trading volume of 60,171,714 shares, compared to its average volume of 13,155,543. The stock has a market cap of $198.20 billion, a PE ratio of 11.49, a P/E/G ratio of 0.82 and a beta of 0.38. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.16 and a current ratio of 1.41. The firm has a fifty day simple moving average of $79.06 and a two-hundred day simple moving average of $87.64. Merck & Co., Inc. has a 52-week low of $73.31 and a 52-week high of $129.93.
Read Our Latest Research Report on MRK
PepsiCo (PEP)
PepsiCo, Inc. engages in the manufacture, marketing, distribution, and sale of various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region.
PEP stock traded up $2.82 during midday trading on Friday, reaching $131.04. The stock had a trading volume of 26,530,795 shares, compared to its average volume of 6,970,251. The stock has a market cap of $179.67 billion, a PE ratio of 19.27, a P/E/G ratio of 3.76 and a beta of 0.45. The company has a debt-to-equity ratio of 2.13, a quick ratio of 0.65 and a current ratio of 0.83. The firm has a fifty day simple moving average of $131.83 and a two-hundred day simple moving average of $142.93. PepsiCo has a 52-week low of $127.60 and a 52-week high of $180.91.
Read Our Latest Research Report on PEP
Exxon Mobil (XOM)
Exxon Mobil Corporation engages in the exploration and production of crude oil and natural gas in the United States and internationally. It operates through Upstream, Energy Products, Chemical Products, and Specialty Products segments. The Upstream segment explores for and produces crude oil and natural gas.
XOM stock traded down $0.59 during midday trading on Friday, reaching $109.40. The stock had a trading volume of 21,995,457 shares, compared to its average volume of 15,722,717. The stock has a market cap of $471.49 billion, a PE ratio of 14.51, a P/E/G ratio of 2.12 and a beta of 0.49. The company has a debt-to-equity ratio of 0.12, a quick ratio of 0.90 and a current ratio of 1.24. The firm has a fifty day simple moving average of $107.04 and a two-hundred day simple moving average of $108.48. Exxon Mobil has a 52-week low of $97.80 and a 52-week high of $126.34.
Read Our Latest Research Report on XOM
Ford Motor (F)
Ford Motor Company develops, delivers, and services a range of Ford trucks, commercial cars and vans, sport utility vehicles, and Lincoln luxury vehicles worldwide. It operates through Ford Blue, Ford Model e, and Ford Pro; Ford Next; and Ford Credit segments. The company sells Ford and Lincoln vehicles, service parts, and accessories through distributors and dealers, as well as through dealerships to commercial fleet customers, daily rental car companies, and governments.
F stock traded up $0.18 during midday trading on Friday, reaching $10.81. The stock had a trading volume of 181,959,522 shares, compared to its average volume of 81,941,495. The stock has a market cap of $42.99 billion, a PE ratio of 8.65, a P/E/G ratio of 0.92 and a beta of 1.50. The company has a debt-to-equity ratio of 2.26, a quick ratio of 0.97 and a current ratio of 1.13. The firm has a fifty day simple moving average of $10.36 and a two-hundred day simple moving average of $9.96. Ford Motor has a 52-week low of $8.44 and a 52-week high of $14.85.
Read Our Latest Research Report on F
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider AbbVie, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AbbVie wasn't on the list.
While AbbVie currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
